{"podcast":{"title":"The Long Run with Luke Timmerman","slug":"the-long-run-with-luke-timmerman-1124799","podcast_index_feed_id":1124799,"rss_url":"https://feeds.soundcloud.com/users/soundcloud:users:317770704/sounds.rss","website_url":"https://soundcloud.com/longrunpodcast","image_url":"https://i1.sndcdn.com/avatars-000334687557-gwdmq9-original.jpg","author":"Timmerman Report","episode_count":203,"summary":"\"The Long Run\" Antarctic explorer Ernest Shackle…","last_synced_at":"2026-07-15T02:19:42.524115+00:00","page_url":"https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799"},"episode":{"title":"Ep188: Art Krieg on Innate Immune System Activators for Cancer","slug":"ep188-art-krieg-on-innate-immune-system-activators-for-cancer","published_at":"2025-10-28T12:54:54+00:00","page_url":"https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep188-art-krieg-on-innate-immune-system-activators-for-cancer","show_page_url":"https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799","url":"https://soundcloud.com/longrunpodcast/ep188-art-krieg-on-innate-immune-system-activators-for-cancer","audio_url":"https://feeds.soundcloud.com/stream/2200719923-longrunpodcast-ep188-art-krieg-on-innate-immune-system-activators-for-cancer.mp3","summary":"Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.","meta_description":"Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.","key_points":[],"chapters":[],"topics":[],"duration_seconds":4145,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep188-art-krieg-on-innate-immune-system-activators-for-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep188-art-krieg-on-innate-immune-system-activators-for-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}